Cell Signaling & Oncology

Axon Ligands™ for Cell Signaling & Oncology Research

The signaling pathways controlling cell growth and differentiation are almost invariably altered in cancer. During the course of tumor progression, cancer cells acquire a number of characteristic alterations. These include the capacities to proliferate independently of exogenous growth-promoting or growth-inhibitory signals, to invade surrounding tissues and metastasize to distant sites, to elicit an angiogenic response, and to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. These properties reflect alterations in the cellular signaling pathways that in normal cells control cell proliferation, motility, and survival. These interconnected pathways are being deciphered, but understanding the alterations that lead to cancer and correcting them is a substantial challenge. Among the key pathways are those controlling cell proliferation, which coordinate a response to the cellular environment, with the mTOR kinase as a critical node. Tumour development is influenced by infections and inflammation, and the complex role of the nuclear factor-B transcription factors is being unravelled. Expansion of tumour cells depends on nutrient supply and vascularization, which is orchestrated by the transcription factor known as HIF. And the metastatic spread of primary tumours to other organs is facilitated by many signaling pathways[1],[2].

Cell Signaling and Oncology products Library

For your convenience, you can order a library of all of our Cell Signaling and Oncology research related products. Make your personal library by cherry picking products of your interest from our comprehensive list (>800 products), or order all together not to miss any. The libraries will be shipped as 10 mM solutions (in DMSO, 250 µL of each selected Axon Ligand™) on a 96-well microtiter plate with a clear map of its contents.

Simply download our comprehensive list of epigenetics products below (Microsoft Excel (.xls)), check the products to be included, and return your list to order the library of your preference.

Axon Ligands™ for Epigenetic research   Axon 5051 - Cell signaling and Oncology Library.xls                   


[1] A. Eccleston, R. Dhand. Signalling in cancer. Nature 441, 423, editorial note
[2] G.S. Martin. Cell signaling and cancer. Cancer Cell. 2003 Sep;4(3):167-74.

15 Item(s)

per page
Axon ID Name Description From price
3144 (+)-Blebbistatin Negative control of (±)-Blebbistatin as an inhibitor of class II myosins €90.00
3074 (-)-Blebbistatin Selective inhibitor of class II myosins; Active enantiomer of (±)-Blebbistatin €90.00
2718 (±)-Blebbistatin Potent and specific inhibitor of class II myosins €95.00
2289 ABT 702 The first, non-nucleoside adenosine kinase (ADK) inhibitor €120.00
4039 CB-103 Orally active protein-protein interaction (PPI) inhibitor of the NOTCH transcriptional activation complex Inquire
4170 CB-5083 First-in-class potent, selective, and orally bioavailable inhibitor of p97 AAA ATPase €110.00
1835 CK 1827452 Cardiac specific myosin ATPase activator €115.00
1826 DBeQ Inhibitor of p97 ATPase €90.00
3216 DCZ0415 AAA-ATPase TRIP13 inhibitor €85.00
1695 Digoxigenin bisdigitoxoside Metabolite of Digoxin €160.00
1649 Digoxin Na+/K+ ATPase pump inhibitor €75.00
3143 KUS121 ATPase inhibitor of valosin-containing protein (VCP) €140.00
2664 LRE1 Allosteric soluble adenylyl cyclase (sAC) inhibitor €95.00
2683 MYK-461 Cardiac specific myosin ATPase inhibitor €120.00
1971 TAK 438 Potassium-competitive acid blocker (P-CAB) €145.00

15 Item(s)

per page
Please wait...